Integer Holdings Corp. Faces Shareholder Claims Over Alleged Misstatements
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jan 14 2026
0mins
Should l Buy ITGR?
Source: Globenewswire
- Shareholder Claims Investigation: Grabar Law Office is investigating claims on behalf of Integer Holdings Corp. shareholders, alleging that certain executives breached their fiduciary duties, potentially leading to corporate reforms and fund recovery for shareholders.
- Allegations of Misstatements: A recently filed securities fraud class action claims that Integer materially misrepresented its competitive position in the EP device market, undermining financial transparency and investor trust.
- Sales Decline Risks: Despite claims of strong visibility into customer demand, the company is reportedly experiencing a sustained decline in sales of its EP devices, which could significantly lower future revenue expectations.
- Potential Legal Consequences: Shareholders who purchased Integer stock before July 25, 2024, and still hold it may face legal repercussions, impacting corporate governance and shareholder rights.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ITGR?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on ITGR
Wall Street analysts forecast ITGR stock price to fall
4 Analyst Rating
2 Buy
2 Hold
0 Sell
Moderate Buy
Current: 86.480
Low
75.00
Averages
86.25
High
95.00
Current: 86.480
Low
75.00
Averages
86.25
High
95.00
About ITGR
Integer Holdings Corporation is a medical device contract development and manufacturing company. The Company serves the cardiac rhythm management, neuromodulation, and cardio and vascular markets. Its brands include Greatbatch Medical and Lake Region Medical. The Company’s Cardio & Vascular product line offers a range of components, subassemblies, and finished devices used in interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology procedures. Its interventional cardiology portfolio is focused primarily on the design, development and manufacture of catheter and wire-based technologies intended to diagnose and treat cardiac disease. Its electrophysiology products include devices used by electrophysiologists and interventional cardiologists for the treatment of cardiac arrythmias, such as atrial fibrillation.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Integer Holdings to Announce Q4 Earnings on February 19
- Earnings Announcement: Integer Holdings is set to release its Q4 2023 earnings report on February 19 before the market opens, with a consensus EPS estimate of $1.70, reflecting an 18.9% year-over-year increase, which could positively impact the stock price due to improved profitability.
- Revenue Expectations: The company anticipates Q4 revenue of $462.72 million, representing a 3.1% year-over-year growth, indicating stability in its market position, which may bolster investor confidence despite modest growth.
- Historical Performance: Over the past two years, Integer Holdings has beaten EPS estimates 75% of the time and revenue estimates 88% of the time, a strong performance record that could attract more investor interest and enhance market expectations for future results.
- Market Dynamics Impact: Although the company faces adverse effects on stock prices due to poor uptake of certain products, the upcoming earnings report and positive performance expectations may provide price support, especially in light of activist investor Irenic's stake acquisition and push for a sale.
See More
Deere & Co Surpasses Q1 Earnings Expectations
- Earnings Beat: Deere & Co reported Q1 earnings of $2.42 per share, exceeding analyst expectations of $2.06, indicating robust performance and boosting investor confidence in the company's prospects.
- Sales Surge: The company achieved quarterly sales of $9.611 billion, significantly surpassing the analyst consensus of $7.686 billion, reflecting strong product demand that could drive sustained growth moving forward.
- Stock Price Surge: Following the earnings report, Deere's stock price jumped 9.1% to $647.09 on Thursday, illustrating market optimism regarding the company's future performance.
- Positive Market Reaction: Despite a broader market decline, Deere's strong financial results allowed it to stand out among stocks, demonstrating resilience and attractiveness in an uncertain market environment.
See More
Integer Holdings Q4 Earnings Exceed Expectations
- Earnings Beat: Integer Holdings reported a Q4 non-GAAP EPS of $1.76, exceeding expectations by $0.06, indicating sustained profitability that may enhance investor confidence.
- Significant Revenue Growth: Q4 revenue reached $472.06 million, a 5.0% year-over-year increase, surpassing expectations by $9.34 million, reflecting strong demand in the cardiovascular and neurovascular sectors, further solidifying market position.
- Strong Cardiovascular Sales: Cardiovascular product sales increased by 11% in Q4 to $284 million, driven by acquisitions of Precision Coating and VSi Parylene, showcasing the company's success in new product launches and market expansion.
- Impressive Full-Year Performance: FY2025 sales grew 17% year-over-year to $1.107 billion, fueled by robust growth from new electrophysiology products and contributions from acquisitions, highlighting the company's future growth potential.
See More
Multiple Companies Face Class Action Lawsuits
- Integer Holdings Lawsuit: Integer Holdings is accused of overstating its competitive position in the EP manufacturing market from July 2024 to October 2025, leading to investor misconceptions about the company's prospects, which could negatively impact its stock price and market trust.
- F5, Inc. Security Incident: F5 failed to disclose a significant security incident during the period from October 2024 to October 2025, placing client security and the company's future prospects at risk, potentially leading to a decline in investor confidence.
- SLM Corporation Delinquency Issues: SLM is alleged to have not disclosed a significant increase in early-stage delinquencies from July to August 2025, misleading investors regarding the effectiveness of its loss mitigation programs, which could affect its financial stability.
- Klarna Group Risk Concealment: Klarna is accused of underestimating the risk of increased loss reserves from September to December 2025, potentially leading to investor misunderstandings about its business prospects, impacting its market performance.
See More
Notice of Class Action Against Integer Holdings
- Class Action Notice: Rosen Law Firm reminds investors who purchased Integer Holdings (NYSE: ITGR) common stock between July 25, 2024, and October 22, 2025, to apply as lead plaintiffs by February 9, 2026, to participate in the class action without any out-of-pocket fees.
- Lawsuit Background: The lawsuit alleges that Integer materially overstated its competitive position in the electrophysiology (EP) manufacturing market and failed to disclose a sustained decline in sales of its EP devices, resulting in investor losses when the truth emerged.
- Law Firm Credentials: Rosen Law Firm specializes in securities class actions and has recovered over $438 million for investors in 2019 alone, being ranked first by ISS Securities Class Action Services in 2017, showcasing its strong reputation in the field.
- Investor Guidance: Investors are advised to carefully select qualified counsel with a proven track record, avoiding firms that merely act as intermediaries, to ensure they receive the best representation and support in the class action.
See More
Integer Holdings Faces Class Action Lawsuit Over Misleading Statements
- Lawsuit Background: Rosen Law Firm has alerted investors about a class action lawsuit on behalf of purchasers of Integer Holdings Corporation (NYSE: ITGR) common stock from July 25, 2024, to October 22, 2025, alleging significant exaggeration of its competitive position in the electrophysiology manufacturing market.
- False Statement Allegations: The lawsuit claims that Integer's assertions of strong visibility into customer demand contradicted the reality of deteriorating sales for two of its electrophysiology devices, resulting in investor losses when the truth emerged.
- Market Impact: As the true details became public, investors realized that Integer's positive statements lacked a reasonable basis, potentially leading to significant stock price impacts and revealing serious misguidance regarding the company's growth prospects in the cardiovascular device sector.
- Legal Proceedings Update: Investors wishing to serve as lead plaintiffs in the class action must file their motions with the court by February 9, 2026, indicating their representative role in the litigation, and they do not need to participate in the case to be eligible for recovery.
See More
Integer Holdings to Announce Q4 Earnings on February 19
- Earnings Announcement: Integer Holdings is set to release its Q4 2023 earnings report on February 19 before the market opens, with a consensus EPS estimate of $1.70, reflecting an 18.9% year-over-year increase, which could positively impact the stock price due to improved profitability.
- Revenue Expectations: The company anticipates Q4 revenue of $462.72 million, representing a 3.1% year-over-year growth, indicating stability in its market position, which may bolster investor confidence despite modest growth.
- Historical Performance: Over the past two years, Integer Holdings has beaten EPS estimates 75% of the time and revenue estimates 88% of the time, a strong performance record that could attract more investor interest and enhance market expectations for future results.
- Market Dynamics Impact: Although the company faces adverse effects on stock prices due to poor uptake of certain products, the upcoming earnings report and positive performance expectations may provide price support, especially in light of activist investor Irenic's stake acquisition and push for a sale.
See More
Deere & Co Surpasses Q1 Earnings Expectations
- Earnings Beat: Deere & Co reported Q1 earnings of $2.42 per share, exceeding analyst expectations of $2.06, indicating robust performance and boosting investor confidence in the company's prospects.
- Sales Surge: The company achieved quarterly sales of $9.611 billion, significantly surpassing the analyst consensus of $7.686 billion, reflecting strong product demand that could drive sustained growth moving forward.
- Stock Price Surge: Following the earnings report, Deere's stock price jumped 9.1% to $647.09 on Thursday, illustrating market optimism regarding the company's future performance.
- Positive Market Reaction: Despite a broader market decline, Deere's strong financial results allowed it to stand out among stocks, demonstrating resilience and attractiveness in an uncertain market environment.
See More
Integer Holdings Q4 Earnings Exceed Expectations
- Earnings Beat: Integer Holdings reported a Q4 non-GAAP EPS of $1.76, exceeding expectations by $0.06, indicating sustained profitability that may enhance investor confidence.
- Significant Revenue Growth: Q4 revenue reached $472.06 million, a 5.0% year-over-year increase, surpassing expectations by $9.34 million, reflecting strong demand in the cardiovascular and neurovascular sectors, further solidifying market position.
- Strong Cardiovascular Sales: Cardiovascular product sales increased by 11% in Q4 to $284 million, driven by acquisitions of Precision Coating and VSi Parylene, showcasing the company's success in new product launches and market expansion.
- Impressive Full-Year Performance: FY2025 sales grew 17% year-over-year to $1.107 billion, fueled by robust growth from new electrophysiology products and contributions from acquisitions, highlighting the company's future growth potential.
See More
Multiple Companies Face Class Action Lawsuits
- Integer Holdings Lawsuit: Integer Holdings is accused of overstating its competitive position in the EP manufacturing market from July 2024 to October 2025, leading to investor misconceptions about the company's prospects, which could negatively impact its stock price and market trust.
- F5, Inc. Security Incident: F5 failed to disclose a significant security incident during the period from October 2024 to October 2025, placing client security and the company's future prospects at risk, potentially leading to a decline in investor confidence.
- SLM Corporation Delinquency Issues: SLM is alleged to have not disclosed a significant increase in early-stage delinquencies from July to August 2025, misleading investors regarding the effectiveness of its loss mitigation programs, which could affect its financial stability.
- Klarna Group Risk Concealment: Klarna is accused of underestimating the risk of increased loss reserves from September to December 2025, potentially leading to investor misunderstandings about its business prospects, impacting its market performance.
See More
Notice of Class Action Against Integer Holdings
- Class Action Notice: Rosen Law Firm reminds investors who purchased Integer Holdings (NYSE: ITGR) common stock between July 25, 2024, and October 22, 2025, to apply as lead plaintiffs by February 9, 2026, to participate in the class action without any out-of-pocket fees.
- Lawsuit Background: The lawsuit alleges that Integer materially overstated its competitive position in the electrophysiology (EP) manufacturing market and failed to disclose a sustained decline in sales of its EP devices, resulting in investor losses when the truth emerged.
- Law Firm Credentials: Rosen Law Firm specializes in securities class actions and has recovered over $438 million for investors in 2019 alone, being ranked first by ISS Securities Class Action Services in 2017, showcasing its strong reputation in the field.
- Investor Guidance: Investors are advised to carefully select qualified counsel with a proven track record, avoiding firms that merely act as intermediaries, to ensure they receive the best representation and support in the class action.
See More
Integer Holdings Faces Class Action Lawsuit Over Misleading Statements
- Lawsuit Background: Rosen Law Firm has alerted investors about a class action lawsuit on behalf of purchasers of Integer Holdings Corporation (NYSE: ITGR) common stock from July 25, 2024, to October 22, 2025, alleging significant exaggeration of its competitive position in the electrophysiology manufacturing market.
- False Statement Allegations: The lawsuit claims that Integer's assertions of strong visibility into customer demand contradicted the reality of deteriorating sales for two of its electrophysiology devices, resulting in investor losses when the truth emerged.
- Market Impact: As the true details became public, investors realized that Integer's positive statements lacked a reasonable basis, potentially leading to significant stock price impacts and revealing serious misguidance regarding the company's growth prospects in the cardiovascular device sector.
- Legal Proceedings Update: Investors wishing to serve as lead plaintiffs in the class action must file their motions with the court by February 9, 2026, indicating their representative role in the litigation, and they do not need to participate in the case to be eligible for recovery.
See More
